We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals

15 hedge funds and large institutions have $85.6M invested in Tonix Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

628% more capital inflows, than outflows

Capital inflows: $44.1M | Capital outflows: $6.06M

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

25% more funds holding

Funds holding: 12 → 15 (+3)

10.8% more ownership

Funds ownership: 12.55% → 23.34% (+11%)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TNXP Hedge Fund Activity: Q2 2021 in Review

15 of the 5,771 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2021, worth a combined $85.6M — up 65% from $52M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TNXP positions and 5 closed out — a net gain of 3 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, adding an estimated $21.3M. The largest seller was Renaissance Technologies, cutting an estimated $1.47M.

  • 15 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2021, up from 12 in Q1 2021.
  • Funds reported $85.6M of Tonix Pharmaceuticals stock for Q2 2021, up 65% quarter-over-quarter.
  • 8 funds opened new Tonix Pharmaceuticals positions in Q2 2021 and 5 closed out, a net change of +3 holders.
  • The largest Tonix Pharmaceuticals buyer in Q2 2021 was BlackRock, an estimated $21.3M added.
  • The largest Tonix Pharmaceuticals seller in Q2 2021 was Renaissance Technologies, an estimated $1.47M sold.

Based on aggregated 13F filings for Q2 2021.